[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [Apellis Pharmaceuticals, Inc. Common Stock](/topic/$apls) ### Sentiment: XX%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$apls/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XXX% +50% **1 Month**: XX% -XX% **6 Months**: XX% -XX% **1 Year**: XX% -XX% **1-Year High**: XXX% on 2025-04-13 **1-Year Low**: X% on 2025-09-09 **Most Supportive Themes** - **Wells Fargo Upgrade:** (15%) Wells Fargo raised Apellis Pharmaceuticals (APLS) target price and rating. **Most Critical Themes** - **Goldman Sachs Downgrade:** (60%) Goldman Sachs downgraded Apellis Pharmaceuticals (APLS) to Sell. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XXX | XX% | XXX | XX% | XX | XX% | | | | | | | | | | Total | XXX | XX% | XXX | XX% | XX | XX% |
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Apellis Pharmaceuticals, Inc. Common Stock
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +50%
1 Month: XX% -XX%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2025-04-13
1-Year Low: X% on 2025-09-09
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XXX | XX% | XXX | XX% | XX | XX% |
Total | XXX | XX% | XXX | XX% | XX | XX% |
/topic/$apls/sentiment